| | | | | Roche's Tecentric immunotherapy mixed with chemotherapy has not yet achieved a hoped-for overall survival target in first-line lung cancer treatment, the Swiss drugmaker said on Thursday. | | |
| | | Novartis said on Thursday it will pay 95 million euros ($110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its foothold in immunology. | | |
| | | Federal prosecutors on Wednesday charged a pharmacy technician who worked at a hospital with making false statements during an investigation related to a Massachusetts compounding pharmacy at the center of a deadly fungal meningitis outbreak in 2012. | | |
| | | Lebanon's parliament is considering legalizing the cultivation of cannabis for medical purposes, Parliament Speaker Nabih Berri said on Wednesday, in an attempt to boost the struggling economy. | | |
| | | (Reuters Health) - Over nearly a decade, deaths from liver disease have been rising rapidly in the U.S., new data show. | | |
| | | (Reuters Health) - Even when traffic fumes permeate the air, it's still better for your heart if you get outside and exercise than if you spend all day sitting inside, a recent study suggests. | | |
| | | (Reuters Health) - Omega-3 fatty acids have long been touted as heart healthy, but taking them in supplement form does little to protect against heart disease, a large new analysis suggests. | | |
| | | AngioDynamics Inc has agreed to pay the U.S. government $12.5 million to resolve allegations it caused healthcare providers to submit false claims to federal healthcare programs over the use of two medical devices, the Justice Department said on Wednesday. | | |
| | | (Reuters Health) - African American men and women are more likely to develop high blood pressure in middle age than their white counterparts, a U.S. study suggests. | | |
| | | (Reuters Health) - Becoming a caregiver for a spouse can be emotionally and physically depleting, and may lead to health declines in the caregiver, according to study from China. | | |
| | | Novartis may ratchet up its 2018 sales outlook, its finance chief said on Wednesday, despite halting planned U.S. drug price hikes amid pressure on the industry from President Donald Trump's administration over the high cost of medicines. | | |
|
| |
